Xiaoliang Wang

7PUBLICATIONS
3CO-AUTHORS
Clinical pharmacology and therapeuticsBiologically active moleculesNeural engineeringPhycology (incl. marine grasses)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 20, 2024
Selective Inhibition of P2Y1 and P2Y12 Receptor Signal Pathways in Platelet Aggregation in Transgenic Cell Lines and Rats by Potassium 2-(1-Hydroxypentyl)-Benzoate, Puerarin and Salvianolic Acid B.

Yiying Li, Weiping Wang, Jie Cai

|Dec 27, 2023
Discovery of 2-Ethoxy-5-isobutyramido-N-1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects.

Jie Zhou, Weiping Wang, Dong Liu

|Apr 21, 2022
The attenuation effect of potassium 2-(1-hydroxypentyl)-benzoate in a mouse model of diabetes-associated cognitive decline: The protein expression in the brain.

Wenwen Yu, Huajing Yin, Yingni Sun

|May 21, 2021
Discovery of Hyperstable Noncanonical Plant-Derived Epidermal Growth Factor Receptor Agonist and Analogs.

Shining Loo, Antony Kam, Bin Bin Li

|Aug 12, 2019
Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model.

Si Shi, Hua-Jing Yin, Jiang Li

|Jul 25, 2018
2-(4-methyl-thiazol-5-yl) ethyl nitrate maleate-potentiated GABAA receptor response in hippocampal neurons.

Xiao-Mei Jiang, Wei-Ping Wang, Zhi-Hui Liu

Pageof 2

Frequent Collaborators

1 joint publications

James P Tam

1 joint publications

Yingni Sun

1 joint publications

Bailing Xu